Similar Jobs
See allClinical Trial Manager II
Summit Therapeutics Inc.
US
Clinical Trial Management
Oncology
GCP
Principal Manager, Clinical Operations Lead
Immatics
US
Clinical Operations
Vendor Management
Oncology
Associate Director, Clinical Operations
Dianthus Therapeutics
Global
Clinical Operations
ICH-GCP
Project Management
Senior Clinical Trial Manager
Ultragenyx
United States
Clinical Trial Management
Vendor Management
Cross-functional Leadership
Senior Clinical Trial Manager
Peptilogics
US
CRO Management
GCP
FDA Regulations
Who We Are:
- Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life and resolving serious unmet medical needs.
- We have multiple global Phase 3 clinical studies, including HARMONi, HARMONi-3, HARMONi-7, and HARMONi-GI3, evaluating ivonescimab in various cancer indications.
Role and Responsibilities:
- Oversees the clinical operational strategy, planning, and execution of one or more global clinical trials.
- Ensures internal clinical and external teams deliver on time, within budget, and in compliance with GCP, ICH guidelines, and applicable regulations.
- Manages CROs, vendors, and strategic partners through robust governance, performance metrics, and risk management.
Experience and Qualifications:
- Bachelor’s degree or equivalent in life science, nursing, pharmacy, or other health-related areas.
- 10+ years of direct clinical trial management experience overseeing phase II/III international oncology clinical trials.
- Ability to travel internationally up to 20% to visit clinical sites and study meetings.
What We Offer:
- Pay transparency: $170,000 - $198,000 USD.
- Total compensation package may include bonus, stock, benefits, and other applicable variable compensation.
- Equal Opportunity Employer committed to creating a diverse environment.
Summit Therapeutics Inc.
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life and resolving serious unmet medical needs. With multiple global Phase 3 clinical studies, the company is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.